PRELUDE THERAPEUTICS INC

Profile

Company Names

PRELUDE THERAPEUTICS INC
PRELUDE THERAPEUTICS INC.

Addresses

200 POWDER MILL ROAD, EXPERIMENTAL STATION E400/3213, WILMINGTON, DE 19803

550 S COLLEGE AVE., STE. 108, NEWARK, DE 19713

550 S COLLEGE AVE., NEWARK, DE 19713

Phone Numbers

(302) 547-3768

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$114,999,966.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-08-21 
$49,999,969.00 
$49,999,969.00 
$0.00 
Equity 
3
2019-05-31 
$29,999,999.00 
$59,999,998.00 
$29,999,999.00 
Equity 
2
2017-10-06 
$29,999,998.00 
$29,999,998.00 
$0.00 
Equity 
1
2016-06-27 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BONITA 
DIRECTOR
VIEWRAY INC   |  ENOBIA PHARMA CORP   |  LOXO ONCOLOGY, INC.   |  TRICIDA, INC.   |  VIEWRAY, INC.   |  ACUTUS MEDICAL, INC.   |  SI-BONE, INC.   |  PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC   |  IMARA INC.   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.   |  ORBIMED GLOBAL HEALTHCARE FUND, L.P.   |  TREELINE BIOSCIENCES, INC.   |  IKENA ONCOLOGY, INC.   |  ADELA, INC.   |  THROMBOLEX, INC.
ANDREW 
 
COMBS 
EXECUTIVE OFFICER
HAMILTON SURGERY CENTER GROUP INC   |  PRELUDE THERAPEUTICS INC
MARDI 
C. 
DIER 
DIRECTOR
PRELUDE THERAPEUTICS INC   |  ORIC PHARMACEUTICALS, INC.
PAUL 
 
FRIEDMAN 
DIRECTOR
STREETLIGHT DATA INC.   |  GOCHARGE, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  BLUEMOUNTAIN CAIS CA LTD.   |  BLUEMOUNTAIN CAIS CA L.P.   |  PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC   |  MEDICOOL TECHNOLOGIES, INC.
JUAN 
 
LUENGO 
EXECUTIVE OFFICER
PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC
DAVID 
 
MAURO 
EXECUTIVE OFFICER
CHECKMATE PHARMACEUTICALS, INC.   |  PRELUDE THERAPEUTICS INC
DEBORAH 
 
MOROSINI 
EXECUTIVE OFFICER
PRELUDE THERAPEUTICS INC
KELVIN 
 
NEU 
DIRECTOR
PRESIDIO PHARMACEUTICALS, INC.   |  PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC   |  ZYMEWORKS INC.
CHRISTOPHER 
 
PIERCE 
EXECUTIVE OFFICER
FANTASYHUB LLC   |  PRELUDE THERAPEUTICS INC
BRIAN 
 
PIPER 
EXECUTIVE OFFICER
PREXA PHARMACEUTICALS INC   |  AEVI GENOMIC MEDICINE, INC.   |  PRELUDE THERAPEUTICS INC   |  SCORPION THERAPEUTICS, INC.   |  ANTARES THERAPEUTICS, INC.
VICTOR 
 
SANDOR 
DIRECTOR
MAGMA TRADING USA, LLC   |  PRELUDE THERAPEUTICS INC   |  ISTARI ONCOLOGY, INC.
PEGGY 
 
SCHERLE 
EXECUTIVE OFFICER
PRELUDE THERAPEUTICS INC
KRISHNA 
 
VADDI 
EXECUTIVE OFFICER, DIRECTOR
PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-08-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-21 
2019-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-31 
2018-08-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-06 
2017-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-06 
2016-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#